QBR-207

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameQBR-207
Drug Alias NameQBR-207
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionComplement C5 inhibitorsComplement C3 inhibitors
TargetsComplement C5Complement C3
Therapy Area/IndicationsGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesQuaerite Biopharm Research Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQuaerite Biopharm Research Ltd
Inactive CompaniesN/A
Active IndicationsGeographic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A